NCT05445609 2025-09-19
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Emory University
Phase 2 Suspended
Emory University
Sorrento Therapeutics, Inc.
Gustave Roussy, Cancer Campus, Grand Paris